Tags |
|
|
Links |
|
|
Actual for You - Fluoroquinolone Antibiotics Classification, Uses and Side Effects
Looking online for a job is a great way to start off on your new career. With the advances in the internet, many retail chains no longer require you to come into the store to fill out a job application in person. Applying for a job via the internet, like with the Home Depot Online Job Application, now allow you to apply for several jobs in one sitting, rather than having to spend hours going from venue to venue. Still, there are some things you should know before you apply online that are relevant to most internet based job applications, including the Home Depot online job application.When you are seeking out applications online, you should always look for job applications that are secure like the Home Depot online job application. Identity theft is a concern of many people when using the internet, and with information filled forms like the Home Depot online job application, a secure website can keep you information private and safe from thieves. Even though you are not including monetary information, you are still sharing a lot of your personal information on your Home Depot online job application and the like. Usually the company will put some sort of notation on the application letting you know it is secure, or there will very often be a “lock” icon at the bottom of you
Fourth Generation. The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan).
Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days.
Side effects
The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects.
Fluoroquinolones are appr
"Unless a man undertakes more than he possibly can do, he will never do all that he can." - Henry DrummondIt’s unanimous… We all want a beautiful body, in fact deep down, most all of us would enjoy having others sneaking peaks at our physiques almost 24/7, especially if we have labored long and hard to develop that divine gift from god. The human body, like our mind and spirit is a collection of delicate intricacies in the making, to be skillfully sculpted into stunning perfection. The body is like a mass of granite or earth waiting to be chiseled into a spectacular masterpiece by its master artisan…You!Lying dormant, the human body has a vast and latent, but explosive potential just waiting to be set free. If chiseled out, carved, molded, whittled and polished, this potential can bend strong steel to submission and lift heavy metal to points of infinity.Like all materials of the physical plane, the human body is presented in its raw form, mostly - untapped. And similar to all raw and natural resources that are rich yet unrefined, the body has to be developed through a committed process. We must clean house of damaging and useless “alloys” (or our fatty-flesh overcoats) to acquire the necessary elements (the muscles). The body must be fully developed into its
The fluoroquinolones are a family of synthetic, broad-spectrum antibacterial agents with bactericidal activity. The parent of the group is nalidixic acid, discovered in 1962 by Lescher and colleagues. The first fluoroquinolones were widely used because they were the only orally administered agents available for the treatment of serious infections caused by gram-negative organisms, including Pseudomonas species.
The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections.
Fluoroquinolones disadvantages:
- Tendonitis or tendon rupture
- Multiple drug interactions
- Not used in children
- Newer quinolones produce additional toxicities to the heart that were not found with the older agents
Fluoroquinolones advantages:
- Ease of administration
- Daily or twice daily dosing
- Excellent oral absorption
- Excellent tissue penetration
- Prolonged half-lives
- Significant entry into phagocytic cells
- Efficacy
- Overall safety
Classification of Fluoroquinolones
As a group, the fluoroquinolones have excellent in vitro activity against a wide range of both gram-positive and gram-negative bacteria. The newest fluoroquinolones have enhanced activity against gram-positive bacteria with only a minimal decrease in activity against gram-negative bacteria. Their expanded gram-positive activity is especially important because it includes significant activity against Streptococcus pneumoniae.
First Generation. The first-generation agents include cinoxacin and nalidixic acid, which are the oldest and least often used quinolones. These drugs had poor systemic distribution and limited activity and were used primarily for gram-negative urinary tract infections. Cinoxacin and nalidixic acid require more frequent dosing than the newer quinolones, and they are more susceptible to the development of bacterial resistance.
Second Generation. The second-generation fluoroquinolones have increased gram-negative activity, as well as some gram-positive and atypical pathogen coverage. Compared with first-generation quinolones, these drugs have broader clinical applications in the treatment of complicated urinary tract infections and pyelonephritis, sexually transmitted diseases, selected pneumonias and skin infections.
Second-generation agents include ciprofloxacin, enoxacin, lomefloxacin, norfloxacin and ofloxacin. Ciprofloxacin is the most potent fluoroquinolone against P. aeruginosa. Ciprofloxacin and ofloxacin are the most widely used second-generation quinolones because of their availability in oral and intravenous formulations and their broad set of FDA-labeled indications.
Third Generation. The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species.
Because of their expanded antimicrobial spectrum, third-generation fluoroquinolones are useful in the treatment of community-acquired pneumonia, acute sinusitis and acute exacerbations of chronic bronchitis, which are their primary FDA-labeled indications. The third-generation fluoroquinolones include levofloxacin, gatifloxacin, moxifloxacin and sparfloxacin.
Fourth Generation. The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan).
Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days.
Side effects
The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects.
Fluoroquinolones are appro
A home equity loan is an amount you borrow against the security of the house that you own. What the lender normally does is take the current market value of the property, deduct outstanding liabilities on it, if any, and lend you the difference (net worth).Some companies limit the loan to 80 or 90 percent of the net worth.You can opt for either Home Equity Line of Credit (HELOC) or Standard Home Equity Loan. In HELOC, you are allowed to draw from the sanctioned amount according to your needs. The interest rate is variable according to changes in the prime rate. A Standard Home Equity Loan is disbursed as a one-time payment. It is to be paid back in equal monthly installments over the approved loan period, which can up to thirty years. In this category, interest is fixed. It is possible for people with poor credit rating also to avail of home equity loans.The borrowed amount can be used for any legitimate purpose that you choose like buying a car or closing a costlier liability. The interest rate is comparatively low, and in most cases, tax-deductible. The shorter the term of the loan, the interest will be lesser. In the U.S., the cost and terms may vary according to the place of residence because there are State regulations.Approval of the loan is normally
- Tendonitis or tendon rupture
- Multiple drug interactions
- Not used in children
- Newer quinolones produce additional toxicities to the heart that were not found with the older agents
Fluoroquinolones advantages:
- Ease of administration
- Daily or twice daily dosing
- Excellent oral absorption
- Excellent tissue penetration
- Prolonged half-lives
- Significant entry into phagocytic cells
- Efficacy
- Overall safety
Classification of Fluoroquinolones
As a group, the fluoroquinolones have excellent in vitro activity against a wide range of both gram-positive and gram-negative bacteria. The newest fluoroquinolones have enhanced activity against gram-positive bacteria with only a minimal decrease in activity against gram-negative bacteria. Their expanded gram-positive activity is especially important because it includes significant activity against Streptococcus pneumoniae.
First Generation. The first-generation agents include cinoxacin and nalidixic acid, which are the oldest and least often used quinolones. These drugs had poor systemic distribution and limited activity and were used primarily for gram-negative urinary tract infections. Cinoxacin and nalidixic acid require more frequent dosing than the newer quinolones, and they are more susceptible to the development of bacterial resistance.
Second Generation. The second-generation fluoroquinolones have increased gram-negative activity, as well as some gram-positive and atypical pathogen coverage. Compared with first-generation quinolones, these drugs have broader clinical applications in the treatment of complicated urinary tract infections and pyelonephritis, sexually transmitted diseases, selected pneumonias and skin infections.
Second-generation agents include ciprofloxacin, enoxacin, lomefloxacin, norfloxacin and ofloxacin. Ciprofloxacin is the most potent fluoroquinolone against P. aeruginosa. Ciprofloxacin and ofloxacin are the most widely used second-generation quinolones because of their availability in oral and intravenous formulations and their broad set of FDA-labeled indications.
Third Generation. The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species.
Because of their expanded antimicrobial spectrum, third-generation fluoroquinolones are useful in the treatment of community-acquired pneumonia, acute sinusitis and acute exacerbations of chronic bronchitis, which are their primary FDA-labeled indications. The third-generation fluoroquinolones include levofloxacin, gatifloxacin, moxifloxacin and sparfloxacin.
Fourth Generation. The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan).
Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days.
Side effects
The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects.
Fluoroquinolones are appr
Here is a quiz. Can a person having a bad credit record and not having any asset as collateral get a loan? The answer is, yes. This is quite possible if he goes for bad credit unsecured loan.Bad credit unsecured loan is uniquely designed a loan for those who are having bad credit records and not having anything to put as collateral. Tenants also can use this loan for they mostly do not have any asset like, a home. In bad credit unsecured loan, the risk factor only is with the lender.Bad credit is not any more regarded as offence these days and most lenders are sympathetic with the borrowers who are facing bad credit record for some unavoidable reasons.However, bad credit unsecured loan charge a bit of higher rates of interest for the loan is being advanced without any security assured and also because these are provided in spite of your bad credit record.One can also use bad credit unsecured loan to improve his credit record, because, when the repayment installments get paid off, the credit record also gets improved automatically. Every paid installment in bad credit unsecured loan is counted as a positive record.Moreover, the bad credit unsecured loan is available online which is, perhaps, the best thing in this loan. One does not have to meet anybod
First Generation. The first-generation agents include cinoxacin and nalidixic acid, which are the oldest and least often used quinolones. These drugs had poor systemic distribution and limited activity and were used primarily for gram-negative urinary tract infections. Cinoxacin and nalidixic acid require more frequent dosing than the newer quinolones, and they are more susceptible to the development of bacterial resistance.
Second Generation. The second-generation fluoroquinolones have increased gram-negative activity, as well as some gram-positive and atypical pathogen coverage. Compared with first-generation quinolones, these drugs have broader clinical applications in the treatment of complicated urinary tract infections and pyelonephritis, sexually transmitted diseases, selected pneumonias and skin infections.
Second-generation agents include ciprofloxacin, enoxacin, lomefloxacin, norfloxacin and ofloxacin. Ciprofloxacin is the most potent fluoroquinolone against P. aeruginosa. Ciprofloxacin and ofloxacin are the most widely used second-generation quinolones because of their availability in oral and intravenous formulations and their broad set of FDA-labeled indications.
Third Generation. The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species.
Because of their expanded antimicrobial spectrum, third-generation fluoroquinolones are useful in the treatment of community-acquired pneumonia, acute sinusitis and acute exacerbations of chronic bronchitis, which are their primary FDA-labeled indications. The third-generation fluoroquinolones include levofloxacin, gatifloxacin, moxifloxacin and sparfloxacin.
Fourth Generation. The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan).
Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days.
Side effects
The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects.
Fluoroquinolones are appr
If you are in the process of applying for a new mortgage or refinancing your existing mortgage there are a number of fees you will have to pay to secure the loan. Here are the basics of costs and terminology associated with your taking out a new mortgage.Mortgage Interest RatesThe interest rate you will qualify for on your mortgage depends on the lender you choose, your credit score, and prevailing interest rates. Qualifying for the lowest rate will save you thousands of dollars in finance charges. When you compare loan offers it is important to compare all aspects of the mortgage, not just the interest rates. If you focus only on interest rates you will probably overpay on the lender fees and closing costs.Discount and Origination PointsPoints come in two flavors: discount points in the form of pre-paid interest and origination points, which are your lender fees. Discount points are paid in exchange for a lower interest rate or more favorable loan terms. One discount point equals one percent of the loan value, paid at closing. The advantage of paying discount points is that you will be able to deduct this fee from your Federal income tax.Closing CostsClosing costs encompass a number of different fees, some paid to the lender, some to th
Third Generation. The third-generation fluoroquinolones are separated into a third class because of their expanded activity against gram-positive organisms, particularly penicillin-sensitive and penicillin-resistant S. pneumoniae, and atypical pathogens such as Mycoplasma pneumoniae and Chlamydia pneumoniae. Although the third-generation agents retain broad gram-negative coverage, they are less active than ciprofloxacin against Pseudomonas species.
Because of their expanded antimicrobial spectrum, third-generation fluoroquinolones are useful in the treatment of community-acquired pneumonia, acute sinusitis and acute exacerbations of chronic bronchitis, which are their primary FDA-labeled indications. The third-generation fluoroquinolones include levofloxacin, gatifloxacin, moxifloxacin and sparfloxacin.
Fourth Generation. The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan).
Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days.
Side effects
The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects.
Fluoroquinolones are appr
At the end of my direct sales presentation Kathy asked if she could book a party. When I went to do her show I was surprised to see another consultant, Lisa, at Kathy's show. I asked Lisa how she knew Kathy and she said with a nervous giggle, "Well, I babysat her kids since they moved here. Kathy didn't realize I'm with this direct selling company so she invited me. That's okay because I wanted to see your presentation."Well, it wasn't okay. This shouldn't have been my booking. It should have been Lisa's. Are you like Lisa? Are you being invited to home party plan demonstrations of your own products? There are many ways to let people know you're in direct sales. Here's just a few of them.1. Never leave home without your business card, catalog, the brochure for this month's specials, and recruiting information. You never know who you could be giving this information to.2. Never take your catalog apart and put the pages in plastic sleeves so you can use the catalogs for the season. Instead, encourage your guest to take your catalog with them. I've gotten huge phone sales and bookings from people I've never met because they got my catalog from someone attending my show.3. Set up a booth at your county fair, summer festival, craft shows, and brid
Fourth Generation. The fourth-generation fluoroquinolones add significant antimicrobial activity against anaerobes while maintaining the gram-positive and gram-negative activity of the third-generation drugs. They also retain activity against Pseudomonas species comparable to that of ciprofloxacin. The fourth-generation fluoroquinolones include trovafloxacin (Trovan).
Because of concern about hepatotoxicity, trovafloxacin therapy should be reserved for life- or limb-threatening infections requiring inpatient treatment (hospital or long-term care facility), and the drug should be taken for no longer than 14 days.
Side effects
The fluoroquinolones as a class are generally well tolerated. Most adverse effects are mild in severity, self-limited, and rarely result in treatment discontinuation. However, they can have serious adverse effects.
Fluoroquinolones are approved for use only in people older than 18. They can affect the growth of bones, teeth, and cartilage in a child or fetus. The FDA has assigned fluoroquinolones to pregnancy risk category C, indicating that these drugs have the potential to cause teratogenic or embryocidal effects. Giving fluoroquinolones during pregnancy is not recommended unless the benefits justify the potential risks to the fetus. These agents are also excreted in breast milk and should be avoided during breast-feeding if at all possible.
- Gastrointestinal effects. The most common adverse events experienced with fluoroquinolone administration are gastrointestinal (nausea, vomiting, diarrhea, constipation, and abdominal pain), which occur in 1 to 5% of patients.
- CNS effects. Headache, dizziness, and drowsiness have been reported with all fluoroquinolones. Insomnia was reported in 3-7% of patients with ofloxacin. Severe CNS effects, including seizures, have been reported in patients receiving trovafloxacin. Seizures may develop within 3 to 4 days of therapy but resolve with drug discontinuation. Although seizures are infrequent, fluoroquinolones should be avoided in patients with a history of convulsion, cerebral trauma, or anoxia. No seizures have been reported with levofloxacin, moxifloxacin, gatifloxacin, and gemifloxacin. With the older non-fluorinated quinolones neurotoxic symptoms such as dizziness occurred in about 50% of the patients.
- Phototoxicity. Exposure to ultraviolet A rays from direct or indirect sunlight should be avoided during treatment and several days (5 days with sparfloxacin) after the use of the drug. The degree of phototoxic potential of fluoroquinolones is as follows: lomefloxacin > sparfloxacin > ciprofloxacin > norfloxacin = ofloxacin = levofloxacin = gatifloxacin = moxifloxacin.
- Musculoskeletal effects. Concern about the development of musculoskeletal effects, evident in animal studies, has led to the contraindication of fluoroquinolones for routine use in children and in women who are pregnant or lactating.
- Tendon damage (tendinitis and tendon rupture). Although fluoroquinolone-related tendinitis generally resolves within one week of discontinuation of therapy, spontaneous ruptures have been reported as long as nine months after cessation of fluoroquinolone use. Potential risk factors for tendinopathy include age >50 years, male gender, and concomitant use of corticosteroids.
- Hepatoxicity. Trovafloxacin use has been associated with rare liver damage, which prompted the withdrawal of the oral preparations from the U.S. market. However, the IV preparation is still available for treatment of infections so serious that the benefits outweigh the risks.
- Cardiovascular effects. The newer quinolones have been found to produce additional toxicities to the heart that were not found with the older compounds. Evidence suggests that sparfloxacin and grepafloxacin may have the most cardiotoxic potential.
- Hypoglycemia/Hyperglycemia. Recently, rare cases of hypoglycemia have been reported with gatifloxacin and ciprofloxacin in patients also receiving oral diabetic medications, primarily sulfonylureas. Although hypoglycemia has been reported with other fluoroquinolones (levofloxacin and moxifloxacin), the effects have been mild.
- Hypersensitivity. Hypersensitivity reactions occur only occasionally during quinolone therapy and are generally mild to moderate in severity, and usually resolve after treatment is stopped.
Conditions treated with Fluoroquinolones: indications and uses
The newer fluoroquinolones have a wider clinical use and a broader spectrum of antibacterial activity including gram-positive and gram-negative aerobic and anaerobic organisms. Some of the newer fluoroquinolones have an important role in the treatment of community-acquired pneumonia and intra-abdominal infections. The serum e
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.actual4u.com/article/252228/actual4u-Fluoroquinolone-Antibiotics-Classification-Uses-and-Side-Effects.html">Fluoroquinolone Antibiotics Classification, Uses and Side Effects</a>
BB link (for phorums):
[url=http://www.actual4u.com/article/252228/actual4u-Fluoroquinolone-Antibiotics-Classification-Uses-and-Side-Effects.html]Fluoroquinolone Antibiotics Classification, Uses and Side Effects[/url]
Related Articles:
List Building – Importance of Building Relationship With Your Subscribers
Bad Credit Unsecured Loan: Well Within Your Reach
Bookmark it:
|